Covid vaccine: Sputnik safest, Pfizer's shot worst? Row over Hungary data

The Russian vaccine has six times lower infection rate than Pfizer's

Sputnik V, Dr Reddy's Laboratories, DRL, coronavirus, vaccine, covid-19
Agencies
1 min read Last Updated : Apr 28 2021 | 12:28 AM IST
The Hungarian government has come out with a table that gives a break-up of the number of infections and deaths after secondary inoculations with the vaccines currently in use in the country.

According to this, Russia’s Sputnik V coronavirus vaccine has been recognised as the safest and most efficient vaccine, while Pfizer performs the worst. Accurate conclusions cannot be drawn from the table since it ignores multiple conditions that would level the playing field of its variables, and allow for the valid comparison of vaccine types, according to a report in Hungary Today.

Earlier, Minister of the Prime Minister’s Office Gergely Gulyás had asserted that the Chinese Sinopharm vaccine and the Russian Sputnik V vaccine are both better than any Western vaccine.

“SputnikV has the best safety (7-32 times fewer deaths cases) and efficacy (2-7 times fewer Covid infections) per 100,000 vaccinated,” according to the vaccine’s official Twitter account. Thus, according to the Hungarian data, Sputnik V has up to 32 times fewer fatalities and six times lower infection rate than the Pfizer vaccine. Hungary was the first European Union nation to receive Sputnik V samples for tests in November 2020.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusPfizerRussiaCoronavirus Vaccine

Next Story